vs

Side-by-side financial comparison of Emerson Electric (EMR) and Wayfair Inc. (W). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $3.3B, roughly 1.3× Wayfair Inc.). Emerson Electric runs the higher net margin — 13.9% vs -3.5%, a 17.4% gap on every dollar of revenue. On growth, Wayfair Inc. posted the faster year-over-year revenue change (6.9% vs 4.1%). Emerson Electric produced more free cash flow last quarter ($602.0M vs $177.0M). Over the past eight quarters, Wayfair Inc.'s revenue compounded faster (10.6% CAGR vs -0.3%).

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

Wayfair Inc. is an American e-commerce company based in Boston, Massachusetts that sells furniture and home goods online. Formerly known as CSN Stores, it was founded in 2002, and currently offers 14 million items from more than 11,000 global suppliers. The company maintains international operations, including locations in North America and in Canada, Germany, Ireland, China and the United Kingdom.

EMR vs W — Head-to-Head

Bigger by revenue
EMR
EMR
1.3× larger
EMR
$4.3B
$3.3B
W
Growing faster (revenue YoY)
W
W
+2.8% gap
W
6.9%
4.1%
EMR
Higher net margin
EMR
EMR
17.4% more per $
EMR
13.9%
-3.5%
W
More free cash flow
EMR
EMR
$425.0M more FCF
EMR
$602.0M
$177.0M
W
Faster 2-yr revenue CAGR
W
W
Annualised
W
10.6%
-0.3%
EMR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EMR
EMR
W
W
Revenue
$4.3B
$3.3B
Net Profit
$605.0M
$-116.0M
Gross Margin
53.2%
30.3%
Operating Margin
17.8%
2.5%
Net Margin
13.9%
-3.5%
Revenue YoY
4.1%
6.9%
Net Profit YoY
3.4%
9.4%
EPS (diluted)
$1.07
$-0.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMR
EMR
W
W
Q4 25
$4.3B
$3.3B
Q3 25
$4.9B
$3.1B
Q2 25
$4.6B
$3.3B
Q1 25
$4.4B
$2.7B
Q4 24
$4.2B
$3.1B
Q3 24
$4.6B
$2.9B
Q2 24
$4.4B
$3.1B
Q1 24
$4.4B
$2.7B
Net Profit
EMR
EMR
W
W
Q4 25
$605.0M
$-116.0M
Q3 25
$637.0M
$-99.0M
Q2 25
$586.0M
$15.0M
Q1 25
$485.0M
$-113.0M
Q4 24
$585.0M
$-128.0M
Q3 24
$996.0M
$-74.0M
Q2 24
$329.0M
$-42.0M
Q1 24
$501.0M
$-248.0M
Gross Margin
EMR
EMR
W
W
Q4 25
53.2%
30.3%
Q3 25
51.9%
30.0%
Q2 25
52.6%
30.1%
Q1 25
53.5%
30.7%
Q4 24
53.5%
30.2%
Q3 24
51.3%
30.3%
Q2 24
52.8%
30.2%
Q1 24
52.2%
30.0%
Operating Margin
EMR
EMR
W
W
Q4 25
17.8%
2.5%
Q3 25
16.4%
1.2%
Q2 25
16.1%
0.5%
Q1 25
14.2%
-4.5%
Q4 24
18.6%
-3.7%
Q3 24
14.7%
-2.6%
Q2 24
10.4%
-1.1%
Q1 24
16.2%
-8.6%
Net Margin
EMR
EMR
W
W
Q4 25
13.9%
-3.5%
Q3 25
13.1%
-3.2%
Q2 25
12.9%
0.5%
Q1 25
10.9%
-4.1%
Q4 24
14.0%
-4.1%
Q3 24
21.6%
-2.6%
Q2 24
7.5%
-1.3%
Q1 24
11.4%
-9.1%
EPS (diluted)
EMR
EMR
W
W
Q4 25
$1.07
$-0.90
Q3 25
$1.12
$-0.76
Q2 25
$1.04
$0.11
Q1 25
$0.86
$-0.89
Q4 24
$1.02
$-1.01
Q3 24
$1.74
$-0.60
Q2 24
$0.57
$-0.34
Q1 24
$0.87
$-2.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMR
EMR
W
W
Cash + ST InvestmentsLiquidity on hand
$1.5B
Total DebtLower is stronger
$7.6B
$3.3B
Stockholders' EquityBook value
$20.3B
$-2.8B
Total Assets
$41.9B
$3.4B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EMR
EMR
W
W
Q4 25
$1.5B
Q3 25
$1.2B
Q2 25
$1.4B
Q1 25
$1.4B
Q4 24
$1.4B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.2B
Total Debt
EMR
EMR
W
W
Q4 25
$7.6B
$3.3B
Q3 25
$8.9B
$2.9B
Q2 25
$8.3B
$3.0B
Q1 25
$8.2B
$3.2B
Q4 24
$6.6B
$3.1B
Q3 24
$7.7B
$3.2B
Q2 24
$7.1B
$3.2B
Q1 24
$7.6B
$3.2B
Stockholders' Equity
EMR
EMR
W
W
Q4 25
$20.3B
$-2.8B
Q3 25
$20.3B
$-2.8B
Q2 25
$19.9B
$-2.7B
Q1 25
$19.2B
$-2.8B
Q4 24
$20.5B
$-2.8B
Q3 24
$21.6B
$-2.7B
Q2 24
$20.8B
$-2.8B
Q1 24
$20.9B
$-2.8B
Total Assets
EMR
EMR
W
W
Q4 25
$41.9B
$3.4B
Q3 25
$42.0B
$3.1B
Q2 25
$42.5B
$3.3B
Q1 25
$42.0B
$3.4B
Q4 24
$42.6B
$3.5B
Q3 24
$44.2B
$3.4B
Q2 24
$45.6B
$3.4B
Q1 24
$46.4B
$3.2B
Debt / Equity
EMR
EMR
W
W
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMR
EMR
W
W
Operating Cash FlowLast quarter
$699.0M
$202.0M
Free Cash FlowOCF − Capex
$602.0M
$177.0M
FCF MarginFCF / Revenue
13.9%
5.3%
Capex IntensityCapex / Revenue
2.2%
0.7%
Cash ConversionOCF / Net Profit
1.16×
TTM Free Cash FlowTrailing 4 quarters
$4.4B
$464.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMR
EMR
W
W
Q4 25
$699.0M
$202.0M
Q3 25
$3.1B
$155.0M
Q2 25
$1.1B
$273.0M
Q1 25
$241.0M
$-96.0M
Q4 24
$777.0M
$162.0M
Q3 24
$3.3B
$49.0M
Q2 24
$1.1B
$245.0M
Q1 24
$743.0M
$-139.0M
Free Cash Flow
EMR
EMR
W
W
Q4 25
$602.0M
$177.0M
Q3 25
$2.7B
$128.0M
Q2 25
$977.0M
$260.0M
Q1 25
$154.0M
$-101.0M
Q4 24
$694.0M
$142.0M
Q3 24
$2.9B
$32.0M
Q2 24
$998.0M
$222.0M
Q1 24
$661.0M
$-152.0M
FCF Margin
EMR
EMR
W
W
Q4 25
13.9%
5.3%
Q3 25
54.9%
4.1%
Q2 25
21.5%
7.9%
Q1 25
3.5%
-3.7%
Q4 24
16.6%
4.5%
Q3 24
63.1%
1.1%
Q2 24
22.8%
7.1%
Q1 24
15.1%
-5.6%
Capex Intensity
EMR
EMR
W
W
Q4 25
2.2%
0.7%
Q3 25
8.9%
0.9%
Q2 25
2.0%
0.4%
Q1 25
2.0%
0.2%
Q4 24
2.0%
0.6%
Q3 24
9.1%
0.6%
Q2 24
2.1%
0.7%
Q1 24
1.9%
0.5%
Cash Conversion
EMR
EMR
W
W
Q4 25
1.16×
Q3 25
4.86×
Q2 25
1.83×
18.20×
Q1 25
0.50×
Q4 24
1.33×
Q3 24
3.35×
Q2 24
3.31×
Q1 24
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

W
W

US Segment$2.9B88%
International Segment$395.0M12%

Related Comparisons